Emergent BioSolutions (EBS) Return on Capital Employed (2016 - 2025)
Historic Return on Capital Employed for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.09%.
- Emergent BioSolutions' Return on Capital Employed rose 2000.0% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 2000.0%. This contributed to the annual value of 0.08% for FY2024, which is 3200.0% up from last year.
- Latest data reveals that Emergent BioSolutions reported Return on Capital Employed of 0.09% as of Q3 2025, which was up 2000.0% from 0.08% recorded in Q2 2025.
- In the past 5 years, Emergent BioSolutions' Return on Capital Employed registered a high of 0.21% during Q1 2021, and its lowest value of 0.6% during Q4 2023.
- Over the past 5 years, Emergent BioSolutions' median Return on Capital Employed value was 0.08% (recorded in 2025), while the average stood at 0.1%.
- In the last 5 years, Emergent BioSolutions' Return on Capital Employed tumbled by -6100bps in 2023 and then surged by 5200bps in 2024.
- Over the past 5 years, Emergent BioSolutions' Return on Capital Employed (Quarter) stood at 0.13% in 2021, then plummeted by -170bps to 0.09% in 2022, then tumbled by -538bps to 0.6% in 2023, then soared by 86bps to 0.09% in 2024, then surged by 206bps to 0.09% in 2025.
- Its last three reported values are 0.09% in Q3 2025, 0.08% for Q2 2025, and 0.08% during Q1 2025.